Establishes the Michael Brandon Cochran Act, requiring C-peptide tests for ICU patients with hypoglycemia and unconscious patients, and creates a.

The Michael Brandon Cochran Act mandates that hospitals administer a C-peptide test to unconscious ICU patients or those with hypoglycemia and a blood glucose level of 49 mg/dl or less. It also requires a post-mortem C-peptide test for patients who die after ICU treatment with suspected brain damage or extended unconsciousness. Hospitals failing to comply face a $10,000 fine per violation. The act establishes a grant program and fund to cover the costs of these tests and training healthcare staff.

Establishes the Michael Brandon Cochran Act, requiring C-peptide tests for ICU patients with hypoglycemia and unconscious patients, and creates a.

The Michael Brandon Cochran Act mandates that hospitals administer a C-peptide test to unconscious ICU patients or those with hypoglycemia and a blood glucose level of 49 mg/dl or less. It also requires a post-mortem C-peptide test for patients who die after ICU treatment with suspected brain damage or extended unconsciousness. Hospitals failing to comply face a $10,000 fine per violation. The act establishes a grant program and fund to cover the costs of these tests and training healthcare staff.